Skip to Main content Skip to Navigation
New interface
Journal articles

Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission

Abstract : We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000-2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We found the following factors predictive of severe NE: nephrotoxic drug exposure (p = 0.005, point value 10); visual disorders (p = 0.02, point value 8); microscopic or macroscopic hematuria (p = 0.04, point value 7); leukocyte count >10 × 109 cells/L (p = 0.01, point value 9); and thrombocytopenia <90 × 109/L (p = 0.003, point value 11). When point values for each factor were summed, we found a score of <10 identified low-risk patients (3.3% had severe disease), and a score >20 identified high-risk patients (45.3% had severe disease). If validated in future studies, this test could be used to stratify patients by severity in research studies and in clinical practice.
Complete list of metadata

Cited literature [45 references]  Display  Hide  Download
Contributor : Jean-Marc Reynes Connect in order to contact the contributor
Submitted on : Tuesday, July 10, 2018 - 2:25:25 PM
Last modification on : Thursday, April 7, 2022 - 10:10:34 AM
Long-term archiving on: : Thursday, October 11, 2018 - 12:50:09 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License




Maxime Hentzien, Stéphanie Mestrallet, Pascale Halin, Laure-Anne Pannet, Delphine Lebrun, et al.. Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission. Emerging Infectious Diseases, 2018, 24 (6), pp.1045 - 1054. ⟨10.3201/eid2406.172160⟩. ⟨pasteur-01834306⟩



Record views


Files downloads